These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10230651)

  • 1. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.
    Kunt T; Schneider S; Pfützner A; Goitum K; Engelbach M; Schauf B; Beyer J; Forst T
    Diabetologia; 1999 Apr; 42(4):465-71. PubMed ID: 10230651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T; Kunt T
    Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.
    Hach T; Forst T; Kunt T; Ekberg K; Pfützner A; Wahren J
    Exp Diabetes Res; 2008; 2008():730594. PubMed ID: 18483566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
    Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
    Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
    Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiological effects of C-peptide].
    Tsimaratos M
    Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
    Nordquist L; Shimada K; Ishii T; Furuya DT; Kamikawa A; Kimura K
    Diabetes Metab Res Rev; 2010 Mar; 26(3):193-9. PubMed ID: 20225182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell deformability in diabetes mellitus: effect of phytomenadione.
    Sabo A; Jakovljević V; Stanulović M; Lepsanović L; Pejin D
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):1-5. PubMed ID: 8444511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.
    Forst T; Kunt T; Pohlmann T; Goitom K; Engelbach M; Beyer J; Pfützner A
    J Clin Invest; 1998 May; 101(10):2036-41. PubMed ID: 9593759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nitric oxide in regulation of deformability of red blood cells in acute phase of endotoxaemia in rats.
    Starzyk D; Korbut R; Gryglewski RJ
    J Physiol Pharmacol; 1997 Dec; 48(4):731-5. PubMed ID: 9444620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute, local effects of iontophoresed insulin and C-peptide on cutaneous microvascular function in Type 1 diabetes mellitus.
    Delaney C; Shaw J; Day T
    Diabet Med; 2004 May; 21(5):428-33. PubMed ID: 15089786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin prevents lipid peroxidation in human erythrocytes but augments deterioration of deformability after in vitro oxidative stress.
    Dikmenoglu N; Ileri E; Seringec N; Ercil D
    Clin Hemorheol Microcirc; 2008; 40(3):235-42. PubMed ID: 19029647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of creatine on erythrocyte rheology in vitro.
    Lipovac V; Gavella M; Vucić M; Mrzljak V; Rocić B
    Clin Hemorheol Microcirc; 2000; 22(1):45-52. PubMed ID: 10711821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium transport across erythrocyte membranes in diabetes mellitus.
    Jennings PE; Wilkins MR; West MJ; Kendall MJ; Barnett AH
    Diabetes Res; 1986 Oct; 3(8):407-10. PubMed ID: 3028693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maurice Dérot Prize 2004. Should C-peptide be put in the insulin bottle?].
    Vague P
    Journ Annu Diabetol Hotel Dieu; 2004; ():231-7. PubMed ID: 15259321
    [No Abstract]   [Full Text] [Related]  

  • 18. C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.
    Johansson BL; Wahren J; Pernow J
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E864-70. PubMed ID: 12799312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial secretogogues and deformability of erythrocytes.
    Korbut RA; Adamek-Guzik T; Madej J; Korbut R
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):655-65. PubMed ID: 12512700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide.
    Joshua IG; Zhang Q; Falcone JC; Bratcher AP; Rodriguez WE; Tyagi SC
    J Cell Biochem; 2005 Dec; 96(6):1149-56. PubMed ID: 16187296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.